Today: 7 February 2026
Subscribe
Browse Category

Financial Analysis News 13 January 2026

Amazon stock (AMZN) drops on report it’s pushing suppliers for cuts as tariff ruling nears

Amazon stock (AMZN) drops on report it’s pushing suppliers for cuts as tariff ruling nears

NEW YORK, Jan 13, 2026, 16:14 EST — After-hours Shares of Amazon.com (AMZN.O) slid 1.6% during Tuesday’s session after reports emerged that the company is pushing suppliers to lower prices ahead of a U.S. Supreme Court ruling on President Donald Trump’s broad tariffs. The stock last traded at $242.60. (Reuters) Why it matters now: tariffs act as import taxes that can quickly shift costs for retailers buying and reselling goods. Amazon’s retail arm is directly caught in the crossfire. The Supreme Court is set to deliver its next rulings on Jan. 14, with the legality of Trump’s global tariff program
13 January 2026
····
Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

New York, Jan 13, 2026, 16:03 EST — After-hours. Tesla shares dipped Tuesday after a new insider filing surfaced and an analyst issued a cautious outlook for 2026. Inflation figures kept hopes alive for rate cuts, supporting some appetite for growth stocks. (Tesla Investor Relations) The electric-vehicle maker’s shares slipped roughly 0.4% to close at $447.31, falling from Monday’s $448.96, market data showed. Timing is key as Tesla approaches its upcoming earnings report, with shares hovering near recent peaks. At the same time, the market wrestles with expectations for interest rates and consumer demand. (Tesla Investor Relations) A recent Form
13 January 2026
····
Figma stock drops 7% after Goldman starts coverage — what NYSE:FIG investors are watching next

Figma stock drops 7% after Goldman starts coverage — what NYSE:FIG investors are watching next

NEW YORK, Jan 13, 2026, 14:59 EST — Regular session Figma’s stock dropped 7% to $33.85 during Tuesday afternoon trading, following Goldman Sachs analyst Gabriela Borges initiating coverage with a Neutral rating and a $40 price target. Volume exceeded its three-month average as shares lingered near the low end of their 52-week range. (StreetInsider.com) The call is significant as Figma continues to search for a stable footing following a volatile post-IPO period. Being a relatively new public company with a slim shareholder base compared to more established software firms, fresh analysis can easily shift its stock. Investors continue to delay
13 January 2026
····
UiPath stock tumbles 9% after CEO Daniel Dines’ share sale filing — what investors watch next

UiPath stock tumbles 9% after CEO Daniel Dines’ share sale filing — what investors watch next

New York, Jan 13, 2026, 14:54 EST — Regular session UiPath shares dropped roughly 9% Tuesday, giving back earlier gains as trading swung wildly. The automation software company started the day at $17.48, climbed to $17.63, then plunged to $15.51 before settling near $15.68. The decline is significant because insider sales, no matter how minor, can dent sentiment in software stocks where investors focus more on future growth than current earnings. UiPath, a popular pick in the “automation plus AI” space, often sees these moves magnified when the market gets volatile. UiPath was active on the investor circuit that day.
13 January 2026
···
iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

New York, Jan 13, 2026, 14:56 (EST) — Regular session Shares of iRhythm Technologies (IRTC) fell 7.5% to $156.24 in Tuesday afternoon trading, following the company’s release of its 2026 sales and profitability goals alongside a plan for corporate restructuring. The timing is key. The update landed right in the middle of the J.P. Morgan Healthcare Conference in San Francisco, a week when medtech and biotech firms typically shape the year’s initial outlook. iRhythm is working hard to reassure investors it can sustain growth as it pushes toward profitability. The company hasn’t published its full 2025 results yet, leaving the
13 January 2026
·····
ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

New York, January 13, 2026, 15:01 ET — Regular session ServiceNow (NOW) slipped 3.3% to $137.95 in afternoon trading Tuesday, following Oppenheimer’s cut to its price target—from $230 down to $200—though the firm kept an “Outperform” rating. The stock underperformed the iShares Expanded Tech-Software Sector ETF, which dropped roughly 2%. This matters as the company prepares to release results amid investor debate over whether enterprise software spending is holding steady or fluctuating. ServiceNow offers cloud software that automates business workflows — exactly the kind of expense that comes under the microscope when budgets tighten. Wall Street turned choppy for growth
13 January 2026
····
Cisco stock gains on inflation day; here’s what CSCO investors watch before Feb. 11 earnings

Cisco stock gains on inflation day; here’s what CSCO investors watch before Feb. 11 earnings

New York, January 13, 2026, 14:23 EST — Regular session Cisco Systems Inc shares climbed roughly 1.3% on Tuesday, bucking a weaker U.S. stock market as investors absorbed new inflation data and adjusted their bets on large-cap tech. The stock traded between $73.27 and $75.07, closing at $74.97. U.S. consumer prices climbed 0.3% in December, pushing annual inflation to 2.7%, according to Labor Department figures. The “core” CPI, which strips out food and energy costs, increased 0.2% for the month and stood at 2.6% year-on-year. Reuters reported the Federal Reserve is likely to keep its benchmark rate steady at 3.50%-3.75%
13 January 2026
····
Why Resolute Holdings Management (RHLD) stock is jumping today — and what to watch next

Why Resolute Holdings Management (RHLD) stock is jumping today — and what to watch next

New York, Jan 13, 2026, 13:48 EST — Regular session Shares of Resolute Holdings Management, Inc. jumped roughly 11% to $234.70 in midday trading Tuesday in New York. The surge followed a regulatory filing detailing a fresh management deal linked to Husky Technologies’ earnings potential. That filing also revealed a planned auditor change for the next fiscal year. This move is significant since Resolute’s model relies on recurring management fees, and the Husky contract brings in an additional revenue stream linked directly to operating results. Resolute calls itself a management company that handles operations and capital allocation at CompoSecure, marketing
13 January 2026
······
Seadrill Limited stock jumps 7% as oil rally blunts Citi downgrade

Seadrill Limited stock jumps 7% as oil rally blunts Citi downgrade

New York, January 13, 2026, 13:51 EST — Regular session underway. Seadrill Ltd shares surged Tuesday, leading offshore drillers higher amid rising crude prices and a boost in energy stocks. The stock climbed 7.0% to $36.01 in afternoon trading, briefly touching $36.03. It started the day at $34.02 and dipped to $34.00 earlier. Trading volume exceeded 420,000 shares. The move follows Citi’s downgrade of Seadrill to “Sell” from “Neutral” just a day earlier, with the price target slashed to $32, according to a note reported by TheFly. Citi highlighted a “downside 30-day catalyst watch” and flagged concerns over rig downtime
13 January 2026
·····
Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

New York, Jan 13, 2026, 13:22 (EST) — Regular session Arcus Biosciences shares rose nearly 5% on Tuesday after Goldman Sachs upgraded the biotech to “Buy” and lifted its price target. The stock was up 4.8% at $22.32 in early afternoon trading. (TipRanks) The call hit in the middle of the J.P. Morgan Healthcare Conference week, when investors often press small and mid-cap biotechs for timelines and trial updates. Arcus is due to present on Wednesday. (Arcus Biosciences) Goldman’s analyst Richard Law pointed to Arcus’s lead program, casdatifan, a HIF-2α inhibitor in development for advanced clear cell renal cell carcinoma,
13 January 2026
·····
Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

New York, Jan 13, 2026, 12:12 PM EST — Regular session Shares of Scorpio Tankers Inc jumped nearly 9% to $59.85 by midday Tuesday, pushing the tanker owner into the ranks of the day’s top performers in shipping. The stock’s strong momentum continued from earlier gains. Timing is key. Product tanker earnings fluctuate with charter rates and route disruptions, while investors zero in on liquidity, especially when firms are juggling ship orders and debt. Scorpio reported holding $793.2 million in cash against $628.4 million in total debt as of Jan. 9, resulting in net cash of $164.7 million—meaning its cash
13 January 2026
····
Lam Research stock stalls near highs as BofA lifts target to $245, more boosts follow

Lam Research stock stalls near highs as BofA lifts target to $245, more boosts follow

New York, Jan 13, 2026, 12:10 EST — Regular session Lam Research (LRCX) shares were little changed on Tuesday after Bank of America raised its price target on the chipmaking equipment supplier to $245 from $195 and kept a Buy rating. The stock was down 0.1% at $220.26 in midday trading. BofA cited a stronger multi-year demand outlook and improving visibility as it lifted targets across its semiconductor equipment coverage. (TipRanks) Why it matters now: Lam is trading near recent highs, and investors are reworking their assumptions for chip-factory spending in 2026. For this group, sentiment can flip fast —
13 January 2026
·····
1 … 91 92 93 94 95 … 287

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop